|Articles|January 22, 2019
PHARMASEAL Launches Engility CTMS
Advertisement
PHARMASEAL, a new provider of clinical trial management and governance solutions, has launched Engility CTMS, the first product to be released from its Engility B2B platform. This new CTMS has been designed in hopes to increase the level of governance and control that organizations demand from their management systems to enable effective oversight of their clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
